Entourage Health Reports Fiscal Year 2023 Financial Results and Posts $54 Million in Total Revenues
TORONTO, April 30, 2024 (GLOBE NEWSWIRE) — Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) (“Entourage” or the “Company“), a Canadian producer and distributor of award-winning cannabis products, announced today its financial results for the fiscal year that ended December 31, 2023. The Company reported a total revenue of $54.1 million, mirroring the previous year’s performance, demonstrating resilience in a competitive market.
Related news for (ETRGF)
- Entourage Health Corp. Announces Closing of Plan of Arrangement
- Entourage Health Increases Senior Secured Credit Facility
- Entourage Health Corp. Announces Shareholder Approval of Going-Private Transaction
- Entourage Health Corp. Enters into Arrangement Agreement for Going-Private Transaction
- Entourage Health Reports Strong Third Quarter 2024 Financial Results